Wright Investors' Service, Feb 2012, Pages: 41
, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of ActiveBiotechAB. There is a textual review of the financial results of ActiveBiotechAB
Life Science Analytics, March 2011, Pages: 102
ActiveBiotechAB-Detailed Product Pipeline provides up to date insight into company’s business description, product information, pipeline details including both summary information and detailed
Life Science Analytics, March 2011, Pages: 124
ActiveBiotechAB-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company
Life Science Analytics, March 2011, Pages: 57
ActiveBiotechAB-Deals & Alliances ReportReport contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category
Global Markets Direct, March 2011, Pages: 58
ActiveBiotechAB – Product Pipeline Review – Q1 2011
Summary
Global Market Direct’s pharmaceuticals report, “ActiveBiotechAB - Product Pipeline Review - Q1 2011” provides data on the company
GlobalData, Aug 2011, Pages: 38
ActiveBiotechAB (ACTI) - Financial and Strategic SWOT Analysis Review
Summary
ActiveBiotechAB (ActiveBiotech) is a Swedish biotechnology company that is specialized developing pharmaceuticals
Decision Resources, Inc., May 2011
The biotech industry continues to face a harsh financing environment, including a tepid initial public offering market and lukewarm venture capital activity. Therefore, biotechs are relying heavily
MP Advisors, Jan 2011, Pages: 150
&A Activities Of mAb Companies
Anti-Infectives : Protease inhibitors will sweep the HCV market, as they did in the case of AIDS. At least two compounds will be approved (telaprevir, boceprevir) before 2012
Bioplan Associates Inc., Jan 2008, Pages: 766
their roots back several thousand years through schools of healing practice. The Indian government is actively developing that experience into a sound biotech industry. We cover Indian government policies
Global Industry Analysts, Inc., April 2011, Pages: 402
Biopharma Launches Borviz in India 58
Bharat Biotech International Unveils COMVAC5® Vaccine 58
14. RECENT INDUSTRY ACTIVITY 59
Bharat Biotech Commences Phase III Clinical Trial with THR-100 59
Bayer
Global Industry Analysts, Inc., April 2011, Pages: 631
)
- Trinity Biotech, PLC (Ireland)
Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources
Wright Investors' Service, Feb 2012, Pages: 42
there are five or more years of data history.
-- Report is included when employee counts are available.
---These reports are not produced for Financial Companies. ActiveBiotechAB, Vita Nova Ventures Ab
Business Insights, March 2010, Pages: 392
Hybridoma technology
RabMAbs
SLAM
Human Response Platform
DIAAD
ImmuneY2
iMAB
Fusion Expression Technology
ProMIS
AbScreen
AbProt
BioArctic platform
FunctionFIRST
Case studies
Abbott Labs
Ab
